Loading…
Forte Biosciences, Inc. is projected to rise to $31.45 by 2027, a +46% move from its current price of $21.47. FBRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $20.55 | $21.49 | $22.47 | +0.07% |
| May 30 | $20.18 | $21.50 | $22.90 | +0.14% |
| May 31 | $19.91 | $21.52 | $23.25 | +0.21% |
| Jun 1 | $19.69 | $21.53 | $23.54 | +0.28% |
| Jun 2 | $19.50 | $21.55 | $23.81 | +0.36% |
| Jun 3 | $19.33 | $21.56 | $24.05 | +0.43% |
| Jun 4 | $19.17 | $21.58 | $24.28 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $19.17 | $21.58 | $24.28 | +0.50% |
| Week 2 | $18.35 | $21.68 | $25.63 | +1.00% |
| Week 3 | $17.76 | $21.79 | $26.74 | +1.50% |
| Week 4 | $17.29 | $21.90 | $27.74 | +2.01% |
| Week 5 | $16.90 | $22.01 | $28.67 | +2.52% |
| Week 6 | $16.56 | $22.12 | $29.55 | +3.03% |
| Week 7 | $16.26 | $22.23 | $30.39 | +3.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
The company's lead product candidate is FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes.
Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Forte Biosciences, Inc. is a healthcare company active in the biotechnology field.
The current price is $21.59. The market cap is $442.14M and the rank is 3131.
The 30-day technical picture shows a range of $15.82 to $29.46, with RSI14 at 40. The SMA50 is $26.86 and the SMA200 is $21.70, with support at $20.07 and resistance at $34.43. These figures frame the near-term price context.
A major floor 48.9% below — a decisive break under it would weaken the trend.
The nearest floor, 6.5% below — buyers have tended to step in here.
The nearest ceiling, 60.4% above — a clean break opens room to run.
A major ceiling 84.8% above — clearing it would confirm fresh momentum.
Key FBRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FBRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.46 | Buy | $21.65 | Sell |
| MA 10 | $22.01 | Sell | $22.30 | Sell |
| MA 20 | $24.29 | Sell | $23.84 | Sell |
| MA 50 | $26.64 | Sell | $25.92 | Sell |
| MA 100 | $28.08 | Sell | $25.71 | Sell |
| MA 200 | $21.81 | Sell | $22.83 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.52 | Neutral |
| Stoch RSI (14) | 53.55 | Neutral |
| CCI (20) | -80.15 | Neutral |
| Williams %R (14) | -77.05 | Info |
| MACD (12,26,9) | -0.19 | Sell |
| ROC (12) | -10.62 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 22.95 | Neutral |
| TRIX (15) | -0.90 | Sell |
| Awesome (5,34) | -5.63 | Sell |
| Ultimate (7,14,28) | 35.19 | Neutral |
| Momentum (10) | -2.82 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 21.69 | Sell |
| ADX (14) | 19.64 | Neutral |
| ATR (14) | 1.05 | Info |
The near-term sentiment is NEUTRAL.
The RSI(14) is 40, indicating modest momentum.
The 30-day picture is framed by the SMA50 at $26.86 and the SMA200 at $21.70, with clear support at $20.07 and resistance at $34.43. The 30-day range runs from $15.82 to $29.46.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $20.07 | $21.47 | $33.84 | 0% | Neutral | |
| $23.41 | $31.45 | $45.52 | +46% | Bullish | |
| $24.79 | $34.94 | $53.34 | +63% | Bullish | |
| $22.23 | $32.63 | $51.93 | +52% | Bullish | |
| $21.36 | $32.53 | $53.61 | +52% | Bullish | |
| $20.04 | $31.59 | $53.66 | +47% | Bullish | |
| $20.78 | $33.84 | $59.03 | +58% | Bullish | |
| $27.92 | $46.88 | $83.80 | +118% | Bullish | |
| $27.63 | $47.79 | $87.34 | +123% | Bullish | |
| $26.62 | $47.40 | $88.40 | +121% | Bullish | |
| $33.14 | $67.70 | $137.41 | +215% | Bullish | |
| $44.86 | $99.69 | $228.16 | +364% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $20.07 | $21.47 | $25.65 | +0.00% |
| June 2026 | $19.42 | $23.12 | $28.42 | +7.70% |
| July 2026 | $18.97 | $22.91 | $28.77 | -0.93% |
| August 2026 | $18.93 | $23.12 | $29.51 | +0.92% |
| September 2026 | $20.13 | $24.80 | $32.08 | +7.27% |
| October 2026 | $20.36 | $25.30 | $33.12 | +2.01% |
| November 2026 | $19.56 | $24.49 | $32.39 | -3.21% |
| December 2026 | $20.09 | $25.34 | $33.84 | +3.48% |
Click any year to see its month-by-month FBRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Forte Biosciences, Inc.'s 2026 outlook centres on $21.47, within a $20.07 to $33.84 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, FBRX could reach as high as $45.52, with a base case around $31.45 and support toward $23.41 — roughly +46% from $21.47. Momentum favours further upside here.
Expect FBRX to range from $24.79 to $53.34 through 2028. The $34.94 average target implies a +63% move from current prices. That is up +11% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The FBRX price prediction for 2029 points to an average of $32.63 (low $22.23, high $51.93) — a potential gain of +52% on today's $21.47. Momentum favours further upside here.
In 2030, FBRX is projected to trade between $21.36 and $53.61, averaging $32.53 — a potential gain of +52% from today's $21.47. That is 0% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Forte Biosciences, Inc.'s 2031 outlook centres on $31.59, within a $20.04 to $53.66 range. That is -3% versus the projected 2030 average. That marks a +47% change versus current levels. Momentum favours further upside here.
By 2032, FBRX could reach as high as $59.03, with a base case around $33.84 and support toward $20.78 — roughly +58% from $21.47. Buyers look set to stay in control over this stretch.
Expect FBRX to range from $27.92 to $83.80 through 2033. The $46.88 average target implies a +118% move from current prices. That is up +39% on the projected 2032 average. Momentum favours further upside here.
The FBRX price prediction for 2034 points to an average of $47.79 (low $27.63, high $87.34) — a potential gain of +123% on today's $21.47. Buyers look set to stay in control over this stretch.
In 2035, FBRX is projected to trade between $26.62 and $88.40, averaging $47.40 — a potential gain of +121% from today's $21.47. That is -1% versus the projected 2034 average. Momentum favours further upside here.
Forte Biosciences, Inc.'s 2040 outlook centres on $67.70, within a $33.14 to $137.41 range. That is up +43% on the projected 2035 average. That marks a +215% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, FBRX could reach as high as $228.16, with a base case around $99.69 and support toward $44.86 — roughly +364% from $21.47. Momentum favours further upside here.
Investing $1,000 in FBRX today (≈ 46.576619 FBRX) could be worth
$4,643.07
+$3,643.07 (+364%) by 2050 · US Dollar
Based on the average projected FBRX price of $99.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FBRXwould be worth at today's price.
$1,000 invested in FBRX on May 27, 2025 (≈ 86.730271 FBRX) would be worth
$1,862.1
+$862.1 (+86.2%) today · 1.86× · US Dollar
Based on a FBRX entry price of $11.53 vs. today's $21.47.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $20.31 | $1,057.11 | +5.7% |
| 1 month ago | $26.8 | $801.12 | -19.9% |
| 3 months ago | $29.26 | $733.77 | -26.6% |
| 6 months ago | $18.56 | $1,156.79 | +15.7% |
| 1 year ago | $11.53 | $1,862.1 | +86.2% |
| All time (5.0y) ago | $913.25 | $23.51 | -97.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FBRX forecast.
Our base-case forecast reaches $43.00 around 2033.
Implied market cap at $43.00: $880.59M
The multi-year outlook shows a bullish trajectory after 2026. The year-by-year path features rising averages and sizable upside potential. For example, the 2027 average price is $32.19 with a max of $47.16 and a min of $23.71, yielding a 49.1 ROI and bullish sentiment.
The path continues with the 2028 average of $35.70 and a max of $55.27, yielding a 65.3 ROI and bullish sentiment, and further advances into 2033 with an average of $48.06 and a max of $87.62 (ROI 122.6). By 2040 the average is projected at $69.55 (max $144.57, min $32.55) with a 222.1 ROI, and by 2050 the average reaches $102.40 (max $235.53, min $46.08) with a 374.3 ROI.
These are estimates, not guarantees, and they reflect a bullish long-run trajectory with year-to-year variability.
Tap a question to reveal the answer.
Min $21.12, Avg $32.79, Max $54.96; ROI 51.9; Sentiment BULLISH.
The forecast shows BULLISH sentiment from 2027 onward, with Avg prices rising to $32.19 in 2027 and $102.40 by 2050, and ROIs from 49.1 to 374.3; 2026 is Neutral with ROI 0.
Yes. The 2040 max is $144.57, and the 2040 avg is $69.55, with the 2050 avg $102.40; the 2040 max exceeds $100.
Current price $21.59; Market cap $442.14M; Rank 3131.
The 30-day range is $15.82 to $29.46.
Forte Biosciences, Inc. Community Discussion
0Share your Forte Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.